文献速递呼吸衰竭与机械通气心脑血管急症重症综合管理与镇静镇痛

多器官床旁超声在重症患者肺栓塞诊断中的准确性:系统评价与Meta分析

Diagnostic accuracy of multi-organ point-of-care ultrasound for pulmonary embolism in critically ill patients: a systematic review and meta-analysis.
PubMed 文献 · Crit Care · 2025-04-23
一句话结论在重症患者中,多器官床旁超声诊断肺栓塞的汇总敏感度0.90、特异度0.69,AUC 0.89,可作为床旁诊断工具,但需进一步研究验证。

该系统评价与Meta分析检索PubMed、Embase、Scopus和Cochrane Library数据库,纳入4项在重症监护病房比较多器官床旁超声与CTPA或通气-灌注扫描诊断肺栓塞的研究,共594例患者。汇总诊断比值比为25.3(95%CI 4.43-82.9),敏感度0.90(95%CI 0.85-0.94;I²=0%),特异度0.69(95%CI 0.42-0.87;I²=95%),阳性似然比3.35(95%CI 1.43-8.02),阴性似然比0.16(95%CI 0.08-0.32),SROC曲线AUC为0.89(95%CI 0.81-0.94)。作者认为多器官床旁超声对重症患者肺栓塞诊断具有高准确性,但需在不同患者群体中进一步研究验证。

要点

  • 多器官床旁超声诊断重症患者肺栓塞的汇总敏感度为0.90(95%CI 0.85-0.94;I²=0%),阴性似然比0.16(95%CI 0.08-0.32)。
  • 汇总特异度为0.69(95%CI 0.42-0.87;I²=95%),异质性高,阳性似然比3.35(95%CI 1.43-8.02)。
  • 汇总诊断比值比为25.3(95%CI 4.43-82.9),SROC曲线AUC为0.89(95%CI 0.81-0.94)。
  • 纳入4项研究共594例,平均年龄55.2至71岁,肺栓塞患病率28%至66.2%,多数研究以CTPA为主要参考标准。
  • 作者结论:多器官床旁超声对重症患者肺栓塞诊断准确性高,但需在不同患者群体中进一步研究验证。

适用人群与场景

  • 在重症监护部门(critical care departments)因疑似肺栓塞而接受评估的危重症患者。
  • 纳入研究比较多器官床旁超声与CTPA或通气-灌注扫描诊断肺栓塞;共4项研究、594例患者,平均年龄55.2至71岁,肺栓塞患病率28%至66.2%。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,检索PubMed、Embase、Scopus和Cochrane Library数据库,纳入4项研究共594例患者。
  • 多器官床旁超声诊断肺栓塞的汇总诊断比值比25.3(95%CI 4.43-82.9),汇总敏感度0.90(95%CI 0.85-0.94;I²=0%),汇总特异度0.69(95%CI 0.42-0.87;I²=95%)。
  • 汇总阳性似然比3.35(95%CI 1.43-8.02),汇总阴性似然比0.16(95%CI 0.08-0.32),SROC曲线AUC 0.89(95%CI 0.81-0.94)。
  • 多数研究以CTPA为主要参考标准;肺栓塞患病率28%至66.2%。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,采用QUADAS-2工具进行质量评价,异质性用I²统计量检验,采用双变量随机效应模型汇总。
  • 局限:作者指出需在不同患者群体中进一步研究验证这些发现。

对床旁实践的改变

  • 作者认为多器官床旁超声对重症患者肺栓塞诊断具有高准确性,可作为床旁诊断工具;但需在不同患者群体中进一步研究验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The clinical presentation of acute pulmonary embolism (PE) can range from mild symptoms to severe shock, circulatory arrest and even death, thereby presenting with a significant high mortality when undiagnosed. Computed tomography pulmonary angiography (CTPA) is the gold-standard imaging modality for diagnosing PE, however, it has several practical limitations and is not widely available in low-income country settings. In this context, point-of-care ultrasound (POCUS) has emerged as a valuable bedside, non-invasive diagnostic tool. This meta-analysis assesses the accuracy of multi-organ POCUS for diagnosing PE in critical care settings.

STUDY DESIGN AND METHODS: We conducted a systematic search of Pubmed, Embase, Scopus and the Cochrane Library databases for studies comparing multi-organ POCUS with CTPA or ventilation-perfusion scans for PE diagnosis in critical care departments. Two reviewers independently completed search, data abstraction and conducted quality assessment with QUADAS-2 tool. Heterogeneity was examined with I2 statistics. We used a bivariate model of random effects to summarize pooled diagnostic odds ratio (DOR), sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR) and summary receiver operating characteristic (SROC).

RESULTS: Four studies met the inclusion criteria, comprising 594 patients. The mean age of participants ranged from 55.2 to 71 years. Prevalence of PE ranged from 28 to 66.2%. CTPA was the primary reference standard used in most studies. Multi-organ POCUS for PE diagnosis demonstrated a pooled DOR of 25.3 (95% CI 4.43-82.9) with a pooled sensitivity of 0.90 (95% CI 0.85-0.94; I2 = 0%) and specificity of 0.69 (95% CI 0.42-0.87; I2 = 95%). The PLR was 3.35 (95% CI 1.43-8.02) and the NLR was 0.16 (95% CI 0.08-0.32). The SROC curve showed an AUC of 0.89 (95% CI 0.81-0.94).

CONCLUSIONS: Multi-organ POCUS has high diagnostic accuracy for PE diagnosis in critically ill patients. Further research is needed to validated these findings across different patient populations.

PROSPERO REGISTRATION: CRD42024614328.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Melo RH, Gioli-Pereira L, Lourenço ID, et al. Diagnostic accuracy of multi-organ point-of-care ultrasound for pulmonary embolism in critically ill patients: a systematic review and meta-analysis. Crit Care. 2025. PMID: 40269937. doi:10.1186/s13054-025-05359-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。